Sonova Holding AG/€SOON

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Sonova Holding AG

Sonova Holding AG is a Swiss company operating in the healthcare industry, specifically focusing on the development, manufacturing, and distribution of hearing care solutions. Its product portfolio includes hearing aids, cochlear implants, wireless communication devices, and professional audiological care services. Founded in 1947, Sonova is headquartered in Stäfa, Switzerland, and serves a global market with its products available in over 100 countries. The company distinguishes itself through continuous innovation in audiological technology and an integrated approach to hearing healthcare, providing both advanced products and comprehensive support services. Sonova’s strategic positioning is enhanced by its focus on research and development, as well as a robust distribution network that includes a mix of retail and wholesale channels.

Ticker

€SOON
Sector

Primary listing

XGAT

Employees

18,351

Headquarters

Stäfa, Switzerland

SOON Metrics

BasicAdvanced
€14B
24.55
€9.75
1.02
€4.69
1.96%

Bulls say / Bears say

Sonova’s fiscal 2024/25 results outperformed expectations, with sales rising 6.6% to CHF 3.87 billion and adjusted EBITA up 4.7% to CHF 807.8 million, beating analyst estimates. (Reuters)
The company forecasts for fiscal 2025/26 project EBITA growth of 14–18% and sales growth of 5–9%, driven by robust business momentum and market share gains from its new product platform launched in August. (Reuters)
Demand for hearing aids remains resilient despite potential U.S. import duties, as these devices are essential health products addressing widespread hearing loss. (Reuters)
U.S. import duties represent a cost headwind that could erode Sonova’s profitability if costs are passed on to consumers or absorbed by the company. (Reuters)
Analysts at Vontobel warn that market uncertainties may temporarily hinder patient inflows, posing a near-term risk to sales momentum. (Reuters)
The impending CEO transition to Eric Bernard in October introduces execution risk and potential strategy disruption after nearly eight years under Arnd Kaldowski. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy €SOON

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs